Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia
SAILLANCE1
Study of Cognitive and Emotional Factors Influencing the Visual Exploration Among Patients With Schizophrenia
2 other identifiers
observational
42
1 country
1
Brief Summary
Background: Patients with schizophrenia are abnormally disturbed by information onsets, which may result in a disadvantage in filtering relevant information. It seems that they accord the same importance to all objects in a scene without taking into account the relevance of objects (cognitive salience) or their emotional charge (salience emotional). The paradigm of change blindness offers the interesting possibility of studying sensitivity to the sudden irruption of visual information with ecological stimuli in schizophrenia. An increased attentional capture by the irruption of visual information would suggest better performance in patients than in healthy controls. Moreover, patients are disturbed to processing of emotional information, in this way we would like to measure the impact of emotional salience on the visual exploration. Main aim: The main objective is to evaluate, if patients with schizophrenia quickly detect changes occurring on irrelevant objects in the understanding of the scene. Secondary objectives: To evaluate in patients with schizophrenia the impact of emotional salience using the same paradigm. To separate an explicit response (motors responses) with an implicit response (eye tracking measures). Methodology: 30 patients with schizophrenia and 30 healthy controls were asked to detect changes in 96 scenes with 0 or 1 change (neutral or emotional changes). We will measure the participants' speed and accuracy in explicitly reporting the changes via motor responses and their capacity to implicitly detect changes via eye movements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 17, 2016
CompletedFirst Posted
Study publicly available on registry
August 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2019
CompletedAugust 26, 2020
August 1, 2020
5.4 years
August 17, 2016
August 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
response time
The explicit response of the participants will be measure behaviourally by response time before the detection of neutral stimuli.
42 months
Secondary Outcomes (3)
sensitivity index
42 months
implicit response
42 months
emotional response
42 months
Study Arms (2)
Patients with schizophrenia
30 patients with schizophrenia (diagnosis based on the standard DSM criteria)
Controls
30 healthy controls without any psychiatric or neurological diagnosis
Eligibility Criteria
30 patients with schizophrenia and 30 healthy controls
You may qualify if:
- Normal or corrected vision
- Affiliate to a social security system
- For group of patients with schizophrenia : diagnosis of schizophrenia based on the standard DSM-IV criteria and patients will be clinically stable at the testing time
You may not qualify if:
- History of neurological illness
- Pregnant and nursing women
- Drugs use in the last 24 hours
- Acute ocular disorder
- Under tutorship, curatorship or deprived of liberty
- For controls group : be free DSM-IV axis-I diagnoses according the MINI test.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital, Lille
Lille, 59037, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume VAIVA
University Hospital, Lille
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2016
First Posted
August 22, 2016
Study Start
July 1, 2014
Primary Completion
November 17, 2019
Study Completion
November 17, 2019
Last Updated
August 26, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share